These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2336712)

  • 41. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen.
    Sayegh MH; Zhang ZJ; Hancock WW; Kwok CA; Carpenter CB; Weiner HL
    Transplantation; 1992 Jan; 53(1):163-6. PubMed ID: 1733066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.
    Ring GH; Saleem S; Dai Z; Hassan AT; Konieczny BT; Baddoura FK; Lakkis FG
    Transplantation; 1999 May; 67(10):1362-5. PubMed ID: 10360591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of class I-MHC antigens by cultured human epidermis and epidermal allografts.
    Mauduit G; Vincent C; Gielen V; Faure M; Demidem A; Thivolet J
    Tissue Antigens; 1987 Feb; 29(2):65-70. PubMed ID: 3299871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of graft interleukin-10 expression in the tolerogenicity of neonatal skin allografts.
    De Fazio SR; Gozzo JJ
    Transplantation; 2000 Nov; 70(9):1371-7. PubMed ID: 11087155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term survival of cardiac allografts in lethally irradiated rats repopulated with host-type hemopoietic cells.
    Dittmer J; Bennett M
    Transplantation; 1975 Apr; 19(4):295-301. PubMed ID: 239473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Skin grafting across H-Y incompatibility after organ culture.
    Wachtel SS; Ninnemann JL; Good RA
    Transplantation; 1975 Jul; 20(1):45-8. PubMed ID: 1101474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged skin grafts survival time by IFN-γ in allogeneic skin transplantation model during acute rejection through IFN-γ/STAT3/IDO pathway in epidermal layer.
    Zhang Y; Wang Y; Wu G; Zhang W; Wang X; Cai W; Zhang J; Han S; Li Y; Bai X; Shi J; Su L; Hu D
    Biochem Biophys Res Commun; 2018 Feb; 496(2):436-442. PubMed ID: 29288671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The abrogation of allosensitization following the induction of mixed allogeneic chimerism.
    Colson YL; Schuchert MJ; Ildstad ST
    J Immunol; 2000 Jul; 165(2):637-44. PubMed ID: 10878335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
    Holán V; Hasek M; Chutná J; Holoubková I
    Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival of neonatal mouse epidermal allografts.
    Steinmuller D
    Transplantation; 1990 Dec; 50(6):1084-6. PubMed ID: 2082984
    [No Abstract]   [Full Text] [Related]  

  • 51. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
    Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection.
    Cleven HA; Genden EM; Moran TM
    Transplantation; 2005 Apr; 79(8):861-8. PubMed ID: 15849536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allogeneic sensitization is more effective than xenogeneic sensitization in eliciting Gal-mediated skin graft rejection.
    Gock H; Murray-Segal L; Salvaris E; Cowan P; D'Apice AJ
    Transplantation; 2004 Mar; 77(5):751-3. PubMed ID: 15021840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro production and transplantation of immunologically active skin equivalents.
    Rouabhia M
    Lab Invest; 1996 Oct; 75(4):503-17. PubMed ID: 8874382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neonatally tolerant rats actively eliminate donor-specific lymphocytes despite persistent chimerism.
    Cutler AJ; Bell EB
    Eur J Immunol; 1996 Feb; 26(2):320-8. PubMed ID: 8617298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.
    Briscoe DM; Dharnidharka VR; Isaacs C; Downing G; Prosky S; Shaw P; Parenteau NL; Hardin-Young J
    Transplantation; 1999 Jun; 67(12):1590-9. PubMed ID: 10401767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of hyporesponsiveness caused by donor-specific transfusion to allogeneic minor antigens.
    Nomoto K; Kanoh K; Suzuki H; Shimura T; Kuwano H
    Eur Surg Res; 2001; 33(3):217-24. PubMed ID: 11490125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice.
    Levite M; Reisner Y
    Transplantation; 1993 Mar; 55(3):633-8. PubMed ID: 8456484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.